Evidence map›Paper›PMID 40361202›Full record

ArticleResearch integrity and peer review2025

Research on policy mechanisms to address funding bias and conflicts of interest in biomedical research: a scoping review.

S Scott Graham, Quinn Grundy, Nandini Sharma, Jade Shiva Edward, Joshua B Barbour, Justin F Rousseau, Zoltan P Majdik, Lisa Bero

Abstract read
In one paragraph

Article in Research integrity and peer review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Promoting informed health choices: the long and winding road.Journal of the Royal Society of Medicine · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S Scott GrahamDepartment of Rhetoric & Writing, The University of Texas at Austin, Austin, TX, USA. ssg@utexas.edu.ORCID http://orcid.org/0000-0003-1569-2428
Quinn GrundyLaurence Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.
Nandini SharmaSoftware and Societal Systems Department, Carnegie Mellon University, Pittsburgh, PA, USA.
Jade Shiva EdwardDepartment of Rhetoric & Writing, The University of Texas at Austin, Austin, TX, USA.
Joshua B BarbourDepartment of Communication, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Justin F RousseauDepartment of Neurology, O'Donnell Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zoltan P MajdikDepartment of Communication, North Dakota State University, Fargo, ND, USA.
Lisa BeroCenter for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Denver, CO, USA.

Funding

Closing the loop with an automatic referral population and summarization systemR01LM014306 · NLM · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yifan Peng, Justin Frederick Rousseau · 2023 to 2026
$2.7M
A Network Science Approach to Conflicts of Interest: Metrics, Policies, and Communication DesignR01GM141476 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BARBOUR, JOSHUA BEN, GRAHAM, SAMUEL · 2021 to 2024
$832k
NIGMS NIH HHS R01 GM141476NIGMS NIH HHS R01GM141476NLM NIH HHS R01 LM014306
6 · The paper itself

Abstract

backgroundIndustry funding and author conflicts of interest (COI) have been consistently shown to introduce bias into agenda-setting and results-reporting in biomedical research. Accordingly, maintaining public trust, diminishing patient harm, and securing the integrity of the biomedical research enterprise are critical policy priorities. In this context, a coordinated and methodical research effort is required to effectively identify which policy interventions are most likely to mitigate against the risks of funding bias. Subsequently this scoping review aims to identify and synthesize the available research on policy mechanisms designed to address funding bias and COI in biomedical research.

methodsWe searched PubMed for peer-reviewed, empirical analyses of policy mechanisms designed to address industry sponsorship of research studies, author industry affiliation, and author COI at any stage of the biomedical research process and published between January 2009 and 28 August 2023. The review identified literature conducting five primary analysis types: (1) surveys of COI policies, (2) disclosure compliance analyses, (3) disclosure concordance analyses, (4) COI policy effects analyses, and (5) studies of policy perceptions and contexts. Most available research is devoted to evaluating the prevalence, nature, and effects of author COI disclosure policies.

resultsSix thousand three hundreds eighty five articles were screened, and 81 studies were included. Studies were conducted in 11 geographic regions, with studies of international scope being the most common. Most available research is devoted to evaluating the prevalence, nature, and effects of author COI disclosure policies. This evidence demonstrates that while disclosure policies are pervasive, those policies are not consistently designed, implemented, or enforced. The available evidence also indicates that COI disclosure policies are not particularly effective in mitigating risk of bias or subsequent negative externalities.

conclusionsThe results of this review indicate that the COI policy landscape could benefit from a significant shift in the research agenda. The available literature predominantly focuses on a single policy intervention-author disclosure requirements. As a result, new lines of research are needed to establish a more robust evidence-based policy landscape. There is a particular need for implementation research, greater attention to the structural conditions that create COI, and evaluation of policy mechanisms other than disclosure.

Indexed as

Competing interestsConflicts of interestFunding biasMeta-researchResearch integrity policy

Identifiers

PMID40361202
PMCPMC12076912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.